Selected article for: "amino acid and bowel disease"
Title: 2018 ACVIM Forum Research Abstract Program: Seattle, Washington, June 14 - 15, 2018
  • Document date: 2018_10_25
    • ID: 60ceejq1_355
    Snippet: Our results show differences between the mucosal proteome of healthy cats, cats with IBD, and cats with SCL. These proteins might hold potential for the development of minimally-invasive biomarkers for the differentiation of IBD and SCL in cats with chronic enteropathy. Further studies to validate these findings are warranted. The essential amino acid tryptophan and its degradation products (e.g., serotonin) are important in the regulation of T-c.....
    Document: Our results show differences between the mucosal proteome of healthy cats, cats with IBD, and cats with SCL. These proteins might hold potential for the development of minimally-invasive biomarkers for the differentiation of IBD and SCL in cats with chronic enteropathy. Further studies to validate these findings are warranted. The essential amino acid tryptophan and its degradation products (e.g., serotonin) are important in the regulation of T-cell response within the intestine as well as intestinal motility. Furthermore, bacteria metabolize tryptophan into various indole-derivatives, which also serve as signaling molecules, activating pathways in other organ systems (e.g., brain, liver, kidney). Alterations in tryptophan metabolism is associated with inflammatory bowel disease (IBD) in humans, and dietary supplementation with tryptophan has been shown to have antiinflammatory effects in experimental colitis models. The aim of this study was to evaluate changes in the tryptophan-serotonin-indole pathway in dogs with intestinal disease.

    Search related documents:
    Co phrase search for related documents
    • bowel disease and colitis model: 1, 2, 3, 4, 5, 6, 7, 8
    • bowel disease and dietary supplementation: 1, 2
    • bowel disease and human IBD inflammatory bowel disease: 1, 2, 3, 4, 5, 6
    • bowel disease and IBD cat: 1
    • bowel disease and IBD inflammatory bowel disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chronic enteropathy and colitis model: 1
    • chronic enteropathy and degradation product: 1
    • chronic enteropathy and dietary supplementation: 1
    • chronic enteropathy and human IBD inflammatory bowel disease: 1
    • chronic enteropathy and IBD inflammatory bowel disease: 1, 2, 3, 4, 5, 6, 7, 8
    • colitis model and dietary supplementation: 1
    • colitis model and IBD inflammatory bowel disease: 1, 2, 3, 4, 5, 6
    • dietary supplementation and IBD inflammatory bowel disease: 1
    • human IBD inflammatory bowel disease and IBD inflammatory bowel disease: 1, 2, 3, 4, 5, 6